Paul Tran, MD
Plastic and Reconstructive Surgery · Valencia, CANPI 1053572396
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,614 of the $5,225 with a category attached, or 69.2%. 18 manufacturers reported payments, led by AbbVie at 43.7% of the total. Reporting peaked in 2023 at $1,897 and has fallen 79.4% since, to $391 in 2025.
Across 71 payments — averaging $73.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Axogen$1K
- Integra Lifesciences Corporation$327
- Mentor Worldwide LLC$247
- Siemens Medical Solutions USA, Inc.$205
- Kls-martin L.p.$156
- plus $545 from 12 others
What the payments were for
- Travel & lodging$1,61131%
- Food & beverage$3,61469%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $2,283 |
| Axogen | 7 | $1,460 |
| Integra Lifesciences Corporation | 6 | $327 |
| Mentor Worldwide LLC | 9 | $247 |
| Siemens Medical Solutions USA, Inc. | 8 | $205 |
| Kls-martin L.p. | 2 | $156 |
| Davol Inc. | 1 | $114 |
| Tepha Inc | 4 | $109 |
| Kerecis Limited | 1 | $53 |
| Johnson & Johnson(2 entities) | 2 | $48 |
| Merz North America, Inc. | 1 | $46 |
| BD | 1 | $44 |
| Merck | 2 | $34 |
| Aroa Biosurgery Incorporated | 1 | $24 |
| Mallinckrodt Enterprises LLC | 2 | $22 |
| Sientra, Inc. | 1 | $20 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVANCE NERVE GRAFT$1,357
- ALLODERM$1,269
- AxoGuard Nerve Connector$1,059
- AxoGuard Nerve Protector$1,059
- NATRELLE SALINE-FILLED BREAST IMPLANTS$555
- SURGIMEND$148
- PHASIX$114
How this compares
$5,225 in reported general payments places this provider in the 70th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 11 | $65 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 17 | $54 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Valencia
- Mark SuskiThousand Oaks$294K
- Corey MaasSan Francisco$286K
- Arian MowlaviLaguna Beach$250K
- Charles LeeSan Francisco$200K
- David SieberSan Francisco$195K
- David KulberLos Angeles$194K
- Matthew NykielUpland$181K
- Subhas GuptaLoma Linda$178K
- Jeffrey HammoudehLos Angeles$159K
- Geoffrey GurtnerPalo Alto$127K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.